MedPath

THUBRIKAR AORTIC VALVE INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Performance Study of the Optimum Transcatheter Aortic Valve

Not Applicable
Recruiting
Conditions
Severe Aortic Stenosis
Interventions
Device: Transcatheter Aortic Valve (TAV) Implantation With The Optimum TAV System
First Posted Date
2019-09-03
Last Posted Date
2022-09-21
Lead Sponsor
Thubrikar Aortic Valve, Inc.
Target Recruit Count
5
Registration Number
NCT04076150
Locations
🇵🇱

John Paul II Hospital, Dept. of Interventional Cardiology, Kraków, Poland

© Copyright 2025. All Rights Reserved by MedPath